How much is the latest price of venetoclax (venetoclax) in 2024 for a box

Venetoclax (venetoclax) has been launched in China and is covered by medical insurance, 10mg*14 tablets, 50mg*7 tablets, 100mg*14 tablets and 100mg*28 tablets. The latest price ranges from a few hundred yuan to several thousand yuan. The latest price of the overseas Turkish version 100 mg*112 tablets is around 1 about 17,000 yuan. There are regular generic drugs on the market in Laos and Bangladesh, with many different specifications. Its pharmaceutical ingredients are basically the same as those of the original drug, and the latest price is around several thousand yuan. Patients should choose to purchase according to their own needs.

Venetoclax is an anti-tumor drug, specifically an inhibitor of Bcell lymphoma factor-2 (BCL-2). It inhibits the activity of the proteasome by directly binding to the BCL-2 protein, thereby inhibiting the growth of tumor cells, killing tumor cells, and delaying the development of tumors. This drug has shown remarkable effectiveness in treating certain types of leukemia.

Veneclat is mainly suitable for newly diagnosed adult patients with acute myeloid leukemia who are not suitable for intensive induction chemotherapy due to comorbidities, or who are aged 75 years and above. It is often used in combination with azacitidine, and this combination therapy can help control the condition and relieve uncomfortable symptoms.

Generally speaking, the dose escalation period for venetoclax is on days 1-3 of the 1 course of treatment, starting from 100m on day 1 gGradually increase to 400mg on day 3 and then maintain the daily dose of 400mg. The medication should be taken with food and the tablet should be swallowed whole and not chewed, crushed or broken.

Some side effects may occur while taking venetoclax, including but not limited to rash, anemia, and neutropenia. In addition, patients may also experience gastrointestinal discomfort, such as nausea, diarrhea and other symptoms. Therefore, patients' blood cell counts and other related indicators should be closely monitored during medication.